Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma

NCT05328167 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05328167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Completed
Start date
December 14, 2021
Completion date
August 31, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholangiocarcinoma